Subsequent analysis of NAP1L5 expression levels across the TCGA-LAML, GSE24395, and GSE114868 datasets showed significant differences between AML patients and healthy controls in all three (Figure 2C), although the observed trends appeared inconsistent. The gene discussed is NAP1L5; the disease is acute myeloid leukemia.